Could Bordetella pertussis vaccine protect against coronavirus COVID-19?. (September 2020)

• Record Type: Journal Article
• Authors: Alkholy, Usama M.; Salama, Mohamed E.; Mahmoud, Hagar; Taher, Ahmed; Elsayes, Khaled M.
• Is Part Of: Journal of global antimicrobial resistance. Volume 22(2020)
• Page Start: 803
• Page End: 805
• Publication Date: 2020-09
• Subjects: Drug resistance -- Periodicals; Drug resistance -- Periodicals; Drug resistance; Periodicals; 616.9041
• DOI: 10.1016/j.jgar.2020.07.005
• Languages: English
• ISSNs: 2213-7165

Abstract

Abstract: According to the World Health Organization (WHO), as of today, there are 2.165.500 confirmed cases of the novel coronavirus disease (COVID-19) and 145.705 deaths in over 185 countries. Unfortunately, despite the tremendous efforts to develop a vaccine initiated by various leading health institutions all over the world, it may be 18 months before a vaccine against the coronavirus is publicly available. We are proposing a theory about testing the use of the Bordetella pertussis vaccine to protect against COVID-19. We deliver this theory to the scientific community, aiming to raise the concern about it, and to provide us with support by realistic and experimental evidence.